Anticardiolipin antibody levels in women undergoing first in vitro fertilization/embryo transfer | Zendy

D. Caccavo | Zendy; N.M. Pellegrino | Zendy; F. Lorusso | Zendy; Mariateresa Capotorto | Zendy; Margherita Vacca | Zendy; Antonella Vimercati | Zendy; Raffaella Depalo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anticardiolipin antibody levels in women undergoing first in vitro fertilization/embryo transfer

Author(s) -

D. Caccavo,

N.M. Pellegrino,

F. Lorusso,

Mariateresa Capotorto,

Margherita Vacca,

Antonella Vimercati,

Raffaella Depalo

Publication year - 2007

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem179

Subject(s) - endometriosis , in vitro fertilisation , embryo transfer , clinical significance , medicine , pregnancy , gynecology , andrology , statistical significance , antibody , embryo , human fertilization , anticardiolipin antibodies , obstetrics , biology , immunology , genetics , anatomy , microbiology and biotechnology

The clinical relevance of antiphospholipid antibodies (aPL) in women undergoing in vitro fertilization/embryo transfer (IVF/ET) and the role of IVF treatment in affecting antiphospholipid levels are controversial. The aim of this study was to evaluate anticardiolipin antibody (aCL) levels and the effect of IVF treatment on aCL in women undergoing their first IVF/ET cycle.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research